Press Release: atai Life Sciences Announces Key Leadership Appointments as it Advances its Pipeline of Novel Psychedelic Therapeutics for Mental Health

Srinivas Rao M.D., Ph.D. succeeds as sole Chief Executive Officer– Kevin Craig, M.D. promoted to Chief Medical Officer– Glenn Short, Ph.D. promoted to Chief Scientific Officer– Gerd Kochendoerfer, Ph.D. joins as Chief Operating Officer NEW YORK and BERLIN, Jan. 10, 2025 (GLOBE NEWSWIRE) — atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company aiming to […]